Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Large-Cell, Anaplastic × Alemtuzumab × 1 year × Clear all

Sponsor

Conditions

Wilms Tumor 1 Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Pseudomyxoma Peritonei 1 Neuroblastoma 1 Neoplasms, Germ Cell and Embryonal 1 Melanoma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Transplantation 1 Digestive System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1 Burkitt Lymphoma 1 Adenocarcinoma, Clear Cell 1

Interventions

Cyclophosphamide 8 Nivolumab 4 Biopsy 4 fludarabine 3 Specimen Handling 3 Prednisone 3 Magnetic Resonance Spectroscopy 3 Etoposide 3 Doxorubicin 3 Brentuximab Vedotin 3 sodium-iodide symporter 2 pembrolizumab 2 fludarabine phosphate 2 cemiplimab 2 X-Rays 2 Whole-Body Irradiation 2 Vincristine 2 Rituximab 2 Positron-Emission Tomography 2 Photons 2 Mycophenolic Acid 2 Ipilimumab 2 Immunoglobulin G 2 Filgrastim 2 Disulfides 2 Cyclosporine 2 CTLA-4 Antigen 2 10-propargyl-10-deazaaminopterin 2 treosulfan 1 talimogene laherparepvec 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡